CPB2 and COVID-19: In conclusion, we showed initial significant generation of CPU with concomitant proCPU consumption during the early phase of SARS-CoV-2 infection, with a subsequent progressive increase in both proCPU concentrations and CPU+CPUi antigen levels in hospitalized COVID-19 patients.